Lipocine Inc.
LPCN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $8 | -$16,352 | -$10,759 | -$634 |
| Dep. & Amort. | $41 | $29 | $9 | $0 |
| Deferred Tax | $0 | $0 | $0 | $160 |
| Stock-Based Comp. | $409 | $654 | $636 | $604 |
| Change in WC | -$964 | $2,008 | -$924 | -$4,595 |
| Other Non-Cash | -$715 | $1,795 | -$932 | $54 |
| Operating Cash Flow | -$1,221 | -$11,866 | -$11,969 | -$4,411 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$90 | -$13 | -$134 | -$8 |
| Net Acquisitions | $0 | $0 | -$14,294 | $43,780,397 |
| Inv. Purchases | -$32,864 | -$22,902 | -$45,074 | -$48,423 |
| Inv. Sales/Matur. | $35,400 | $36,000 | $59,502 | $4,650 |
| Other Inv. Act. | $0 | $0 | $14,294 | -$43,780,397 |
| Investing Cash Flow | $2,446 | $13,085 | $14,294 | -$43,780 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$2,317 | -$3,333 |
| Stock Issued | $209 | $405 | $0 | $30,247 |
| Stock Repurch. | $0 | $0 | -$22 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $211 | $12 |
| Financing Cash Flow | $209 | $405 | -$2,127 | $26,925 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,434 | $1,623 | $198 | -$21,267 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,772 | $3,148 | $2,951 | $24,217 |
| End Cash | $6,206 | $4,772 | $3,148 | $2,951 |
| Free Cash Flow | -$1,311 | -$11,879 | -$12,103 | -$4,419 |